{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-044550","form_type":"8-K","ticker":"IDXG","cik":"0001054102","company_name":"INTERPACE BIOSCIENCES, INC.","filed_at":"2023-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.055791+00:00","generated_at":"2026-06-07T13:57:32.978654+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Director Robert Gorman resigns from Interpace board, cites compensation dispute","bullets":["Robert Gorman resigned as director and Chairman effective December 7, 2023.","Resignation not due to any disagreement with company's operations, policies, or practices.","Gorman disagreed with timing of proposed change from Executive Chairman to Chairman and reduction in compensation."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-044550","json":"https://secwatch.observer/filing/0001493152-23-044550.json","markdown":"https://secwatch.observer/filing/0001493152-23-044550.md","text":"https://secwatch.observer/filing/0001493152-23-044550.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1054102/000149315223044550/0001493152-23-044550-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1054102/000149315223044550/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T13:57:32.978654+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a8cc79d5e7","claim":"Robert Gorman resigned as Director and Chairman at INTERPACE BIOSCIENCES, INC..","evidence_excerpt":"On December 7, 2023, Robert Gorman, a Class II director designated by Ampersand 2018 Limited Partnership to the board of directors (the “ Board ”) of Interpace Biosciences, Inc. (the “ Company ”), provided notice to the Company of his resignation as a director and as Chairman of the Board, including as a member of the Board’s Regulatory Compliance Committee, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1054102/000149315223044550/0001493152-23-044550-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director and Chairman"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}